SU Yudong, CHEN Jinliang, CHEN Peng. Rare Adverse Reaction to Anlotinib in Treatment of Thoracic Carcinoma: A Case Report of Dry Eye Syndrome[J]. Cancer Research on Prevention and Treatment, 2024, 51(12): 1057-1060. DOI: 10.3971/j.issn.1000-8578.2024.24.0726
Citation:
|
SU Yudong, CHEN Jinliang, CHEN Peng. Rare Adverse Reaction to Anlotinib in Treatment of Thoracic Carcinoma: A Case Report of Dry Eye Syndrome[J]. Cancer Research on Prevention and Treatment, 2024, 51(12): 1057-1060. DOI: 10.3971/j.issn.1000-8578.2024.24.0726
|
SU Yudong, CHEN Jinliang, CHEN Peng. Rare Adverse Reaction to Anlotinib in Treatment of Thoracic Carcinoma: A Case Report of Dry Eye Syndrome[J]. Cancer Research on Prevention and Treatment, 2024, 51(12): 1057-1060. DOI: 10.3971/j.issn.1000-8578.2024.24.0726
Citation:
|
SU Yudong, CHEN Jinliang, CHEN Peng. Rare Adverse Reaction to Anlotinib in Treatment of Thoracic Carcinoma: A Case Report of Dry Eye Syndrome[J]. Cancer Research on Prevention and Treatment, 2024, 51(12): 1057-1060. DOI: 10.3971/j.issn.1000-8578.2024.24.0726
|